<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:49:36 -0700</creation_date>
  <update_date>2013-05-27 11:09:44 -0600</update_date>
  <accession>HMDBP00278</accession>
  <secondary_accessions>
    <accession>5510</accession>
    <accession>HMDBP04351</accession>
    <accession>HMDBP05539</accession>
    <accession>HMDBP08997</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>AADC</synonym>
    <synonym>DDC</synonym>
    <synonym>DOPA decarboxylase</synonym>
  </synonyms>
  <gene_name>DDC</gene_name>
  <general_function>Involved in carboxy-lyase activity</general_function>
  <specific_function>Catalyzes the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine.
</specific_function>
  <pathways>
    <pathway>
      <name>dopamine biosynthesis</name>
      <smpdb_id/>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Histidine metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00340</kegg_map_id>
    </pathway>
    <pathway>
      <name>Tyrosine metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00350</kegg_map_id>
    </pathway>
    <pathway>
      <name>Phenylalanine metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00360</kegg_map_id>
    </pathway>
    <pathway>
      <name>Tryptophan metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00380</kegg_map_id>
    </pathway>
    <pathway>
      <name>Serotonergic synapse</name>
      <smpdb_id/>
      <kegg_map_id>map04726</kegg_map_id>
    </pathway>
    <pathway>
      <name>Dopaminergic synapse</name>
      <smpdb_id/>
      <kegg_map_id>map04728</kegg_map_id>
    </pathway>
    <pathway>
      <name>Cocaine addiction</name>
      <smpdb_id/>
      <kegg_map_id>map05030</kegg_map_id>
    </pathway>
    <pathway>
      <name>Amphetamine addiction</name>
      <smpdb_id/>
      <kegg_map_id>map05031</kegg_map_id>
    </pathway>
    <pathway>
      <name>Alcoholism</name>
      <smpdb_id/>
      <kegg_map_id>map05034</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00177</accession>
      <name>L-Histidine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00870</accession>
      <name>Histamine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00159</accession>
      <name>L-Phenylalanine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02117</accession>
      <name>Oleamide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00732</accession>
      <name>Hydroxykynurenine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04076</accession>
      <name>5-Hydroxykynurenamine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00472</accession>
      <name>5-Hydroxy-L-tryptophan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00259</accession>
      <name>Serotonin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00929</accession>
      <name>L-Tryptophan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00303</accession>
      <name>Tryptamine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00073</accession>
      <name>Dopamine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00181</accession>
      <name>L-Dopa</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01491</accession>
      <name>Pyridoxal 5'-phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00609</accession>
      <name>DL-Dopa</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01967</accession>
      <name>Carbon dioxide</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14336</accession>
      <name>Carbidopa</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14405</accession>
      <name>Cycloserine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15013</accession>
      <name>Flupenthixol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15051</accession>
      <name>Amantadine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15627</accession>
      <name>Droxidopa</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02017</accession>
      <name>1-Phenylethylamine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15571</accession>
      <name>Oxitriptan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12275</accession>
      <name>Phenylethylamine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00158</accession>
      <name>L-Tyrosine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00306</accession>
      <name>Tyramine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12819</accession>
      <name>5-Hydroxykynurenine</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>cofactor binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>pyridoxal phosphate binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>lyase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>carbon-carbon lyase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>carboxy-lyase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>organic acid metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>oxoacid metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>carboxylic acid metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>cellular metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>cellular amino acid and derivative metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>physiological process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolism</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>cellular metabolism</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>amino acid and derivative metabolism</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>amino acid metabolism</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>axon</description>
      <go_id>GO:0030424</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>cytosol</description>
      <go_id>GO:0005829</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>neuronal cell body</description>
      <go_id>GO:0043025</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>synaptic vesicle</description>
      <go_id>GO:0008021</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>amino acid binding</description>
      <go_id>GO:0016597</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>aromatic-L-amino-acid decarboxylase activity</description>
      <go_id>GO:0004058</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>pyridoxal phosphate binding</description>
      <go_id>GO:0030170</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>catecholamine biosynthetic process</description>
      <go_id>GO:0042423</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular amino acid metabolic process</description>
      <go_id>GO:0006520</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to alkaloid</description>
      <go_id>GO:0071312</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to drug</description>
      <go_id>GO:0035690</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular response to growth factor stimulus</description>
      <go_id>GO:0071363</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>circadian rhythm</description>
      <go_id>GO:0007623</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>dopamine biosynthetic process</description>
      <go_id>GO:0042416</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>indolalkylamine biosynthetic process</description>
      <go_id>GO:0046219</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>isoquinoline alkaloid metabolic process</description>
      <go_id>GO:0033076</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>multicellular organismal aging</description>
      <go_id>GO:0010259</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>phytoalexin metabolic process</description>
      <go_id>GO:0052314</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to pyrethroid</description>
      <go_id>GO:0046684</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>serotonin biosynthetic process</description>
      <go_id>GO:0042427</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>synaptic vesicle amine transport</description>
      <go_id>GO:0015842</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>7</chromosome_location>
    <locus>7p12.2</locus>
    <gene_sequence>&gt;1443 bp
ATGAACGCAAGTGAATTCCGAAGGAGAGGGAAGGAGATGGTGGATTACGTGGCCAACTAC
ATGGAAGGCATTGAGGGACGCCAGGTCTACCCTGACGTGGAGCCCGGGTACCTGCGGCCG
CTGATCCCTGCCGCTGCCCCTCAGGAGCCAGACACGTTTGAGGACATCATCAACGACGTT
GAGAAGATAATCATGCCTGGGGTGACGCACTGGCACAGCCCCTACTTCTTCGCCTACTTC
CCCACTGCCAGCTCGTACCCGGCCATGCTTGCGGACATGCTGTGCGGGGCCATTGGCTGC
ATCGGCTTCTCCTGGGCGGCAAGCCCAGCATGCACAGAGCTGGAGACTGTGATGATGGAC
TGGCTCGGGAAGATGCTGGAACTACCAAAGGCATTTTTGAATGAGAAAGCTGGAGAAGGG
GGAGGAGTGATCCAGGGAAGTGCCAGTGAAGCCACCCTGGTGGCCCTGCTGGCCGCTCGG
ACCAAAGTGATCCATCGGCTGCAGGCAGCGTCCCCAGAGCTCACACAGGCCGCTATCATG
GAGAAGCTGGTGGCTTACTCATCCGATCAGGCACACTCCTCAGTGGAAAGAGCTGGGTTA
ATTGGTGGAGTGAAATTAAAAGCCATCCCCTCAGATGGCAACTTCGCCATGCGTGCGTCT
GCCCTGCAGGAAGCCCTGGAGAGAGACAAAGCGGCTGGCCTGATTCCTTTCTTTATGGTT
GCCACCCTGGGGACCACAACATGCTGCTCCTTTGACAATCTCTTAGAAGTCGGTCCTATC
TGCAACAAGGAAGACATATGGCTGCACGTTGATGCAGCCTACGCAGGCAGTGCATTCATC
TGCCCTGAGTTCCGGCACCTTCTGAATGGAGTGGAGTTTGCAGATTCATTCAACTTTAAT
CCCCACAAATGGCTATTGGTGAATTTTGACTGTTCTGCCATGTGGGTGAAAAAGAGAACA
GACTTAACGGGAGCCTTTAGACTGGACCCCACTTACCTGAAGCACAGCCATCAGGATTCA
GGGCTTATCACTGACTACCGGCATTGGCAGATACCACTGGGCAGAAGATTTCGCTCTTTG
AAAATGTGGTTTGTATTTAGGATGTATGGAGTCAAAGGACTGCAGGCTTATATCCGCAAG
CATGTCCAGCTGTCCCATGAGTTTGAGTCACTGGTGCGCCAGGATCCCCGCTTTGAAATC
TGTGTGGAAGTCATTCTGGGGCTTGTCTGCTTTCGGCTAAAGGGTTCCAACAAAGTGAAT
GAAGCTCTTCTGCAAAGAATAAACAGTGCCAAAAAAATCCACTTGGTTCCATGTCACCTC
AGGGACAAGTTTGTCCTGCGCTTTGCCATCTGTTCTCGCACGGTGGAATCTGCCCATGTG
CAGCGGGCCTGGGAACACATCAAAGAGCTGGCGGCCGACGTGCTGCGAGCAGAGAGGGAG
TAG</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>480</residue_number>
    <molecular_weight>53893.755</molecular_weight>
    <theoretical_pi>7.197</theoretical_pi>
    <pfams>
      <pfam>
        <name>Pyridoxal_deC</name>
        <pfam_id>PF00282</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;Aromatic-L-amino-acid decarboxylase
MNASEFRRRGKEMVDYVANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDV
EKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGCIGFSWAASPACTELETVMMD
WLGKMLELPKAFLNEKAGEGGGVIQGSASEATLVALLAARTKVIHRLQAASPELTQAAIM
EKLVAYSSDQAHSSVERAGLIGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMV
ATLGTTTCCSFDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFN
PHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQIPLGRRFRSL
KMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEICVEVILGLVCFRLKGSNKVN
EALLQRINSAKKIHLVPCHLRDKFVLRFAICSRTVESAHVQRAWEHIKELAADVLRAERE
</protein_sequence>
  </protein_properties>
  <genbank_protein_id>41393464</genbank_protein_id>
  <uniprot_id>P20711</uniprot_id>
  <uniprot_name>DDC_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>3RBF</pdb_id>
    <pdb_id>3RBL</pdb_id>
    <pdb_id>3RCH</pdb_id>
  </pdb_ids>
  <genbank_gene_id>M76180</genbank_gene_id>
  <genecard_id>DDC</genecard_id>
  <geneatlas_id>DDC</geneatlas_id>
  <hgnc_id>HGNC:2719</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Ichinose H, Kurosawa Y, Titani K, Fujita K, Nagatsu T: Isolation and characterization of a cDNA clone encoding human aromatic L-amino acid decarboxylase. Biochem Biophys Res Commun. 1989 Nov 15;164(3):1024-30.</reference_text>
      <pubmed_id>2590185</pubmed_id>
    </reference>
    <reference>
      <reference_text>Scherer LJ, McPherson JD, Wasmuth JJ, Marsh JL: Human dopa decarboxylase: localization to human chromosome 7p11 and characterization of hepatic cDNAs. Genomics. 1992 Jun;13(2):469-71.</reference_text>
      <pubmed_id>1612608</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sumi-Ichinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T: Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry. 1992 Mar 3;31(8):2229-38.</reference_text>
      <pubmed_id>1540578</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7.  Nature. 2003 Jul 10;424(6945):157-64.</reference_text>
      <pubmed_id>12853948</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Le Van Thai A, Coste E, Allen JM, Palmiter RD, Weber MJ: Identification of a neuron-specific promoter of human aromatic L-amino acid decarboxylase gene. Brain Res Mol Brain Res. 1993 Mar;17(3-4):227-38.</reference_text>
      <pubmed_id>8510497</pubmed_id>
    </reference>
    <reference>
      <reference_text>Craig SP, Thai AL, Weber M, Craig IW: Localisation of the gene for human aromatic L-amino acid decarboxylase (DDC) to chromosome 7p13--&amp;gt;p11 by in situ hybridisation. Cytogenet Cell Genet. 1992;61(2):114-6.</reference_text>
      <pubmed_id>1395716</pubmed_id>
    </reference>
    <reference>
      <reference_text>Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231-8.</reference_text>
      <pubmed_id>10391209</pubmed_id>
    </reference>
    <reference>
      <reference_text>Chang YT, Sharma R, Marsh JL, McPherson JD, Bedell JA, Knust A, Brautigam C, Hoffmann GF, Hyland K: Levodopa-responsive aromatic L-amino acid decarboxylase deficiency.  Ann Neurol. 2004 Mar;55(3):435-8.</reference_text>
      <pubmed_id>14991824</pubmed_id>
    </reference>
    <reference>
      <reference_text>Pons R, Ford B, Chiriboga CA, Clayton PT, Hinton V, Hyland K, Sharma R, De Vivo DC: Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis. Neurology. 2004 Apr 13;62(7):1058-65.</reference_text>
      <pubmed_id>15079002</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>L-Tryptophan</name>
        <accession>HMDB00929</accession>
      </metabolite>
      <reference>
        <reference_text>Tyce GM: Origin and metabolism of serotonin.  J Cardiovasc Pharmacol. 1990;16 Suppl 3:S1-7.</reference_text>
        <pubmed_id>1369709</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Dopa</name>
        <accession>HMDB00181</accession>
      </metabolite>
      <reference>
        <reference_text>BIRKMAYER W, HORNYKIEWICZ O: [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].  Wien Klin Wochenschr. 1961 Nov 10;73:787-8.</reference_text>
        <pubmed_id>13869404</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Carbidopa</name>
        <accession>HMDB14336</accession>
      </metabolite>
      <reference>
        <reference_text>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database.  Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</reference_text>
        <pubmed_id>11752352</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Carbidopa</name>
        <accession>HMDB14336</accession>
      </metabolite>
      <reference>
        <reference_text>Durso R, Evans JE, Josephs E, Szabo G, Evans B, Fernandez HH, Browne TR: Variable absorption of carbidopa affects both peripheral and central levodopa metabolism. J Clin Pharmacol. 2000 Aug;40(8):854-60.</reference_text>
        <pubmed_id>10934669</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Carbidopa</name>
        <accession>HMDB14336</accession>
      </metabolite>
      <reference>
        <reference_text>Yee RE, Cheng DW, Huang SC, Namavari M, Satyamurthy N, Barrio JR: Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA.  Biochem Pharmacol. 2001 Nov 15;62(10):1409-15.</reference_text>
        <pubmed_id>11709201</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Carbidopa</name>
        <accession>HMDB14336</accession>
      </metabolite>
      <reference>
        <reference_text>Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R: Norepinephrine precursor therapy in neurogenic orthostatic hypotension.  Circulation. 2003 Aug 12;108(6):724-8. Epub 2003 Jul 28.</reference_text>
        <pubmed_id>12885750</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Carbidopa</name>
        <accession>HMDB14336</accession>
      </metabolite>
      <reference>
        <reference_text>Orlefors H, Sundin A, Lu L, Oberg K, Langstrom B, Eriksson B, Bergstrom M: Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography. Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):60-5. Epub 2005 Sep 24.</reference_text>
        <pubmed_id>16184369</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Carbidopa</name>
        <accession>HMDB14336</accession>
      </metabolite>
      <reference>
        <reference_text>Calabrese V, Mancuso C, Ravagna A, Perluigi M, Cini C, De Marco C, Butterfield DA, Stella AM: In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state. J Neurochem. 2007 May;101(3):709-17. Epub 2007 Jan 4.</reference_text>
        <pubmed_id>17241115</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Carbidopa</name>
        <accession>HMDB14336</accession>
      </metabolite>
      <reference>
        <reference_text>Gilbert JA, Frederick LM, Ames MM: The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Clin Cancer Res. 2000 Nov;6(11):4365-72.</reference_text>
        <pubmed_id>11106255</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Cycloserine</name>
        <accession>HMDB14405</accession>
      </metabolite>
      <reference>
        <reference_text>DENGLER HJ, RAUCHS E, RUMMEL W: [On the inhibition of L-glutamic acid and L-DOPA decarboxylase by D-cycloserine and other isoxazolidones]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1962;243:366-81.</reference_text>
        <pubmed_id>13885421</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Flupenthixol</name>
        <accession>HMDB15013</accession>
      </metabolite>
      <reference>
        <reference_text>Zhu MY, Juorio AV, Paterson IA, Boulton AA: Regulation of aromatic L-amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists. Br J Pharmacol. 1994 May;112(1):23-30.</reference_text>
        <pubmed_id>7913379</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Amantadine</name>
        <accession>HMDB15051</accession>
      </metabolite>
      <reference>
        <reference_text>Li XM, Juorio AV, Qi J, Boulton AA: Amantadine increases aromatic L-amino acid decarboxylase mRNA in PC12 cells. J Neurosci Res. 1998 Aug 15;53(4):490-3.</reference_text>
        <pubmed_id>9710269</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Amantadine</name>
        <accession>HMDB15051</accession>
      </metabolite>
      <reference>
        <reference_text>Fisher A, Biggs CS, Starr MS: Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase. Amino Acids. 1998;14(1-3):43-9.</reference_text>
        <pubmed_id>9871440</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Droxidopa</name>
        <accession>HMDB15627</accession>
      </metabolite>
      <reference>
        <reference_text>Goldstein DS: L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug.  Cardiovasc Drug Rev. 2006 Fall-Winter;24(3-4):189-203.</reference_text>
        <pubmed_id>17214596</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Droxidopa</name>
        <accession>HMDB15627</accession>
      </metabolite>
      <reference>
        <reference_text>Maruyama W, Naoi M, Narabayashi H: [The effect of droxidopa on the monoamine metabolsim in the human brain].  Rinsho Shinkeigaku. 1994 Oct;34(10):985-90.</reference_text>
        <pubmed_id>7834959</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
